ISRCTN10633953已完成未知
Multinational CMV Outcomes, Treatment Patterns and Healthcare Resource Utilization Study (OTUS) Following Solid Organ Transplant (SOT)
Takeda (United States)0 个研究点目标入组 218 人开始时间: 2021年11月25日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 218
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Aged =18 years at the time of the SOT
- •2. Received a SOT after January 1, 2014
- •3. Diagnosed with CMV infection any time after the SOT date
- •4. Required =1 anti-CMV agent to manage CMV infection and were (a) resistant to currently available treatments OR (b) refractory to currently available treatments OR (c) considered intolerant to currently available treatments
- •5. Follow-up data are available for at least 12 months (1 year) after being characterized in item #4 (above) or until death, whichever occurs first
排除标准
- •Positive test for HIV before the SOT
研究者
相似试验
已完成
不适用
Cytomegalovirus (CMV) in allogeneic hematopoietic stem cell transplant patientsISRCTN78128786Takeda (United States)379
已完成
不适用
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and CanadaCytomegalovirus (CMV)NCT05571137Takeda118
招募中
不适用
International comparison of Treatment approaches and Outcomes in adolescents and Young adults with anorexia nervosaF50.0F50.1Atypical anorexia nervosaAnorexia nervosaDRKS00015787Charité Campus Virchow-Klinikum175
已完成
不适用
Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 InfectionCovid19NCT04651400Octapharma300
已完成
不适用
Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)Lung CancerNCT04031898AstraZeneca896